Highlights

Trader Hub

Author: traderhub8   |   Latest post: Wed, 18 Sep 2019, 9:14 AM

 

China Everbright Water Limited – Enter Into New Market and Water Business

Author:   |    Publish date:


  • Both 1Q19 revenue and PATMI met our expectations.
  • 40 projects in the pipeline: 16 under construction, 3 commenced construction, and 21 in the preparatory stage.
  • Less intense competition and more reasonable project valuations in the industry.
  • Entered into new drinking water project in Zhejiang province
  • We maintain our BUY recommendation and target price of S$0.50 based on the unchanged FY19e EPS of 5.5 SG cents and the peers’ PER of 9.0.

 

The Positives

New business and new footprint amid a stable growth. As of June-19, CEWL secured 11 new projects and signed one supplementary agreement for an existing project with a total investment of RMB3.7bn. Meanwhile, the company expanded the businesses scope to asset-light models by undertaking two engineering, procurement and construction and one operations and maintenance projects with a contract size of RMB146mn. It is worth noting that CEWL extended the footprint to a new provincial market, securing the first drinking water sources wetland project in Zhejiang province in 2Q19. There are 40 projects in the pipeline, including 16 under construction, 3 commenced construction, and 21 in the preparatory stage.  Another eight more projects received tariff hikes ranging from 4% to 56% in 1H19. The total designed daily water treatment capacity exceeded 6mn tonnes.

 

Outlook

After several years of reform in the WWT industries, the competition becomes less intense as the underperformed or unperformed projects or companies have been phased out or incorporated by the quality market participant. According to management, the valuation of projects trends to be more reasonable at the juncture. Therefore, the room for both organic and inorganic growth swells. Meanwhile, the company has widened its business into tapping into drinking water business and asset-light models that are expected to enhance ROE marginally. We foresee a robust and stable growing performance in the next couple of years.

 

Maintain BUY with an unchanged TP of S$0.50

We maintain our target price to S$0.50 based on the unchanged FY19e EPS of 5.5 SG cents and the peers’ PER of 9.0, and we keep the BUY recommendation.

Source: Phillip Capital Research - 16 Aug 2019

Share this

Related Stocks

Chart Stock Name Last Change Volume 
China Everbright 0.315 0.00 (0.00%) 595 

  Be the first to like this.
 


 

131  133  162  676 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 Rex Intl 0.088-0.005 
 TEE Intl 0.046+0.004 
 YZJ Shipbldg SGD 1.05-0.03 
 Spackman 0.013+0.001 
 Mapletree Ind Tr 2.40+0.07 
 Keppel DC Reit 1.97+0.04 
 Kep Infra Tr 0.525+0.005 
 LionGold 0.0010.00 
 Medtecs Intl 0.039+0.007 
 Mapletree Com Tr 2.22+0.06 
Partners & Brokers